Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | Director | June 30, 2025 | July 02, 2025 |
| Myovant Sciences Ltd.MYOV · Entity 115677 | Director | August 18, 2017 | October 20, 2017 |
| NISOURCE INC.NI · Entity 3270 | Director | May 25, 2021 | May 27, 2021 |
| Surgery Partners, Inc.SGRY · Entity 4534 | Director · Exec Chairman of the Board | March 21, 2025 | March 25, 2025 |
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | Chief Financial Officer | September 22, 2026 | September 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date June 30, 2025 · Filed July 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,523.274 |
Reported balance
After 2025-06-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-30 · Grant · Acquired 602 · Balance 19,523.274 F1: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. |
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.57 · Expires 2032-02-07 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements.
Myovant Sciences Ltd.
Report date August 18, 2017 · Filed October 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.14 · Expires 2027-08-17 | Direct | 22,500 |
Reported balance
After 2017-08-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-08-18 · Grant · Acquired 22,500 · Balance 22,500 F1: 100% of the shares underlying the option vest and become exercisable on the earlier of (a) August 18, 2018, and (b) the date that is one day prior to the Issuer's 2018 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the shares underlying the option vest and become exercisable on the earlier of (a) August 18, 2018, and (b) the date that is one day prior to the Issuer's 2018 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date.
NISOURCE INC.
Report date May 25, 2021 · Filed May 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,480.185 |
Reported balance
After 2021-05-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-25 · Grant · Acquired 5,922 · Balance 35,480.185 F1: Represents an award of restricted stock units ("RSU") granted as part of the non-employee director's annual compensation and which vests in full on the last day of the director's annual term for which the RSUs are awarded, subject to certain acceleration conditions. RSUs represent a contingent right to receive one share of the Company's common stock upon vesting pursuant to the Company's 2020 Omnibus Plan. F2: This amount includes 989.03 RSUs received pursuant to the dividend equivalent provisions of the RSU awards and which are subject to the same vesting conditions as the underlying RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSU") granted as part of the non-employee director's annual compensation and which vests in full on the last day of the director's annual term for which the RSUs are awarded, subject to certain acceleration conditions. RSUs represent a contingent right to receive one share of the Company's common stock upon vesting pursuant to the Company's 2020 Omnibus Plan.
F2: This amount includes 989.03 RSUs received pursuant to the dividend equivalent provisions of the RSU awards and which are subject to the same vesting conditions as the underlying RSUs.
Surgery Partners, Inc.
Report date March 21, 2025 · Filed March 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,203 |
Reported balance
After 2025-03-21 transaction · row 1
1 source rowRow 1 · 2025-03-21 · Grant · Acquired 4,233 · Balance 105,203 F1: Represents restricted stock awards ("RSAs") granted to the reporting person on March 21, 2025 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock awards ("RSAs") granted to the reporting person on March 21, 2025 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
UNITEDHEALTH GROUP INC
Report date September 22, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,675.758 |
Reported balance
After 2026-09-22 transaction · row 1
1 source rowRow 1 · 2026-09-22 · Grant · Acquired 106.233 · Balance 18,675.758 F1: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Sep 24, 2026 20:12 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 106.233 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000223 · wk-form4_1790280750.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,675.758 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:10 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,208.895 | $399.66 | $483,146.98 |
DisclosureSEC source: 0000731766-26-000203 · wk-form4_1788552611.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,569.525 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:37 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 111.76 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000164 · wk-form4_1782423441.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,778.69 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:33 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 149.989 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000100 · wk-form4_1773952435.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,666.93 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:07 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 35,517 | $0.00 Strike: $282.34 | $0.00 |
DisclosureSEC source: 0000731766-26-000048 · wk-form4_1772053637.xml · derivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,517 Underlying: Common Stock · 35,517 shares Expires 2036-02-23 F2 · derivative.exercise_date: The non-qualified stock options vest at a rate of 25% annually on February 23 from the years 2027 through 2030. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:07 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 8,855 | $282.34 | $2,500,120.70 |
DisclosureSEC source: 0000731766-26-000048 · wk-form4_1772053637.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,516.941 F1 · shares: The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:12 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 70.042 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-25-000344 · wk-form4_1766095976.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,661.941 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| September 23, 2025 Filed Sep 25, 2025 20:16 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 66.899 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-25-000280 · wk-form4_1758831385.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,591.899 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:24 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 42,551 | $0.00 Strike: $308.80 | $0.00 |
DisclosureSEC source: 0000731766-25-000243 · wk-form4_1757017438.xml · derivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,551 Underlying: Common Stock · 42,551 shares Expires 2035-09-02 F2 · derivative.exercise_date: The non-qualified stock options vest at a rate of 25% annually on September 2 from the years 2026 through 2029. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:24 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 10,525 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-25-000243 · wk-form4_1757017438.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,525 F1 · shares: The restricted stock units vest at a rate of 25% annually on September 2 from the years 2026 through 2029 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:58 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 602 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000143 · wk-form4_1751489920.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,523.274 F1 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:23 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000111 · wk-form4_1747257804.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,921.274 F1 · shares: This award includes 3,579 shares of restricted stock units which will vest in full on the earlier of May 13, 2026, or the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:07 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 541 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000073 · wk-form4_1743628025.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,342.274 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:32 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 4,233 | $24.21 | $102,480.93 |
DisclosureSEC source: 0001638833-25-000079 · wk-form4_1742934766.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,203 F1 · shares: Represents restricted stock awards ("RSAs") granted to the reporting person on March 21, 2025 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:53 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000008 · wk-form4_1735941175.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,801.274 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:11 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000183 · wk-form4_1727903494.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,263.274 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:35 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000145 · wk-form4_1719956132.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,827.274 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 14, 2024 Filed May 16, 2024 22:14 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 2,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000120 · wk-form4_1715897657.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,337.274 F1 · shares: This award includes 2,916 shares of restricted stock units which will vest in full on the earlier of May 14, 2025, and the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 23:37 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 420.93 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000088 · wk-form4_1712101020.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,421.274 F1 · balance_after: Ownership includes 2,947 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 23:29 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 537.15 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000006 · wk-form4_1704324531.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000.344 F1 · balance_after: Ownership includes 2,947 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:55 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GiftCommon Stock | 30,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-24-000002 · wk-form4_1704232491.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,970 F1 · kind: Bona fide gift of common stock to a charitable donor-advised fund. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 22:17 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $12.90 | $0.00 |
DisclosureSEC source: 0001104659-23-128319 · tm2333534-2_4seq1.xml · derivative · entry 3 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,090,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option to purchase shares is fully vested. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 22:17 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 168,130 | $33.44 | $5,622,267.20 |
DisclosureSEC source: 0001104659-23-128319 · tm2333534-2_4seq1.xml · nonDerivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,870 Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 22:17 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionCommon Stock | 100,000 | $12.90 | $1,290,000.00 |
DisclosureSEC source: 0001104659-23-128319 · tm2333534-2_4seq1.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 22:50 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 582.444 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000196 · wk-form4_1696373448.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,463.194 F1 · balance_after: Ownership includes 2,947 shares of restricted stock subject to vesting requirements. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 23:41 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 581.047 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000175 · wk-form4_1688600464.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,880.75 F1 · balance_after: Ownership includes 2,947 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:35 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GiftCommon Stock | 18,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-23-000071 · wk-form4_1684269341.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Bona fide gift of common stock to a charitable donor-advised fund. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 2,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000139 · wf-form4_168393008159584.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,299.703 F1 · balance_after: Ownership includes 2,947 shares of restricted stock which will vest in full on the earlier of May 10, 2024 and the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 01:15 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 440.203 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000101 · wf-form4_168065734674976.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,352.703 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 20:46 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 20,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-23-000054 · wf-form4_168003634876655.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,999 F1 · shares: The Compensation Committee approved this award of unrestricted common stock in lieu of, and in full settlement of, a portion of the cash incentive award earned by the Reporting Person under the Issuer's cash incentive plan for performance in 2022. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:08 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 382.591 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000015 · wf-form4_167287729218250.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912.5 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:29 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 349.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000345 · wf-form4_166493208080854.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,529.909 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 23:48 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 376.234 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000267 · wf-form4_165706489167199.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,180.239 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:23 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 7,397 | $55.89 | $413,418.33 |
DisclosureSEC source: 0001638833-22-000099 · wf-form4_165178218119677.xml · nonDerivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,591 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:23 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 52,603 | $55.68 | $2,928,935.04 |
DisclosureSEC source: 0001638833-22-000099 · wf-form4_165178218119677.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,988 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 26, 2022 Filed Apr 29, 2022 01:08 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 2,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000201 · wf-form4_165119441806366.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,804.005 F1 · balance_after: Ownership includes 2,323 shares of restricted stock which will vest in full on the earlier of April 26, 2023 and the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:38 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 381.005 | $82.02 | $31,250.03 |
DisclosureSEC source: 0001071739-22-000145 · wf-form4_164911905077688.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481.005 F1 · balance_after: Ownership includes 1,100 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 21:43 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 6,727 | $50.88 | $342,269.76 |
DisclosureSEC source: 0001638833-22-000075 · wf-form4_164755340620918.xml · nonDerivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,591 F3 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:43 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 8,621 | $49.30 | $425,015.30 |
DisclosureSEC source: 0001638833-22-000075 · wf-form4_164755340620918.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,318 F1 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 23:40 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 966 | $55.11 | $53,236.26 |
DisclosureSEC source: 0001638833-22-000043 · wf-form4_164730118751788.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,939 F1 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 10, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2022 Filed Feb 10, 2022 00:33 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $80.57 | $0.00 |
DisclosureSEC source: 0001071739-22-000058 · wf-form4_164445320625619.xml · derivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-02-07 F2 · derivative.exercise_date: The options vest in three equal installments on the anniversary of the grant beginning on February 7, 2023. Read SEC document |
| February 07, 2022 Filed Feb 10, 2022 00:33 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000058 · wf-form4_164445320625619.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F1 · balance_after: Ownership includes 1,100 shares of restricted stock vesting on the date of the April 2022 Annual Meeting of Stockholders. Read SEC document |
| May 25, 2021 Filed May 27, 2021 01:26 UTC | NISOURCE INC. NI · Entity 3270 | GrantCommon Stock | 5,922 | $25.33 | $150,004.26 |
DisclosureSEC source: 0001127602-21-018105 · form4.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,480.185 F1 · shares: Represents an award of restricted stock units ("RSU") granted as part of the non-employee director's annual compensation and which vests in full on the last day of the director's annual term for which the RSUs are awarded, subject to certain acceleration conditions. RSUs represent a contingent right to receive one share of the Company's common stock upon vesting pursuant to the Company's 2020 Omnibus Plan. F2 · balance_after: This amount includes 989.03 RSUs received pursuant to the dividend equivalent provisions of the RSU awards and which are subject to the same vesting conditions as the underlying RSUs. Read SEC document |
| March 26, 2021 Filed Mar 29, 2021 18:18 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 1,247 | $43.75 | $54,556.25 |
DisclosureSEC source: 0001638833-21-000096 · wf-form4_161704190829089.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,905 F1 · date: The transaction date and the amount of securities beneficially owned were adjusted to correct an administrative error on the Form 4 filed on March 25, 2021. F1 · balance_after: The transaction date and the amount of securities beneficially owned were adjusted to correct an administrative error on the Form 4 filed on March 25, 2021. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 19:27 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 2,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-21-000084 · wf-form4_161670041831832.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,250 F1 · shares: The Compensation Committee approved this award of unrestricted common stock in lieu of, and in full settlement of, 50% of the cash incentive award earned by the Reporting Person under the Issuer's cash incentive plan for performance in 2020. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:39 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 6,780 | $42.06 | $285,166.80 |
DisclosureSEC source: 0001638833-21-000066 · wf-form4_161601713259218.xml · nonDerivative · entry 2 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,349 F2 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 15, 2021 of restricted stock. Read SEC document |
| March 13, 2021 Filed Mar 17, 2021 21:39 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 9,946 | $42.06 | $418,328.76 |
DisclosureSEC source: 0001638833-21-000066 · wf-form4_161601713259218.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,129 F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 13, 2021 of restricted stock. Read SEC document |
| March 10, 2021 Filed Mar 24, 2021 17:16 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 5,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-21-000070 · wf-form4_161660617861158.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,295 F1 · shares: Shares will vest in three equal annual installments of each of the first three anniversaries of March 10, 2021. Read SEC document |
| May 19, 2020 Filed May 21, 2020 15:20 UTC | NISOURCE INC. NI · Entity 3270 | GrantCommon Stock | 5,965.293 | $23.05 | $137,500.00 |
DisclosureSEC source: 0001127602-20-017454 · form4.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,569.155 F1 · shares: Represents an award of restricted stock units ("RSU") granted as part of the non-employee director's annual compensation and which vests in full on the last day of the director's annual term for which the RSUs are awarded, subject to certain acceleration conditions. RSUs represent a contingent right to receive one share of the Company's common stock upon vesting pursuant to the Company's 2020 Omnibus Plan. F2 · balance_after: This amount includes 433.208 RSUs received pursuant to the dividend equivalent provisions of the RSU awards and which are subject to the same vesting conditions as the underlying RSUs. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:24 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 112,348 | $6.62 | $743,743.76 |
DisclosureSEC source: 0001638833-20-000028 · wf-form4_158568622580665.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,075 F1 · shares: The Compensation Committee approved this award of unrestricted common stock in lieu of, and in full settlement of, the cash incentive award earned by the Reporting Person under the Issuer's cash incentive plan for performance in 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.